Bill Text: CT HB05962 | 2017 | General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: An Act Prohibiting Insurers From Using Step Therapy For Prescription Drugs Prescribed To Treat Stage Iv Metastatic Cancer.

Spectrum: Committee Bill

Status: (Introduced - Dead) 2017-03-17 - Favorable Change of Reference, Senate to Committee on Appropriations [HB05962 Detail]

Download: Connecticut-2017-HB05962-Introduced.html

---

General Assembly		Proposed Bill No. 5962
January Session, 2017		LCO No. 1618
		*01618*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
REP. ORANGE, 48th Dist.

AN ACT PROHIBITING INSURERS AND OTHER ENTITIES FROM REQUIRING THAT INSUREDS DIAGNOSED WITH METASTATIC CANCER USE STEP THERAPY FOR ANY PRESCRIBED DRUG PRESCRIBED TO TREAT METASTATIC CANCER.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

That title 38a of the general statutes be amended to prohibit any insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing any health insurance policy or contract from requiring that insureds diagnosed with metastatic cancer use step therapy for any prescribed drug prescribed to treat metastatic cancer.

Statement of Purpose:

To prohibit insurance companies and other entities from requiring that insureds diagnosed with metastatic cancer use step therapy for any prescribed drug prescribed to treat metastatic cancer.